Transcatheter aortic valve replacement (TAVR) is a contemporary, non-surgical option for high-risk surgical patients with severe aortic valve stenosis. Studies have shown that TAVR is non-inferior to surgical aortic valve replacement. TAVR is also less invasive than conventional surgery and its advantages are reflected in the lower rates of acute kidney injury, atrial fibrillation, and shorter hospital stays. Studies have also shown TAVR to be cost-effective which will certainly prove to be beneficial for patients.
Docplexus has organized an interactive Webinar on 10 th December 2018 at 2 pm . In this webinar session, Dr. Ravinder Singh Rao will talk about TAVR – Promise Of Non-Surgical Approach For Severe Aortic Stenosis Patients. We invite you to submit your questions which will be answered by the speaker at the end of the session.
